Clinical Trial Update: Trial of Hydrocortisone for Post-Traumatic Stress Disorder (PTSD) [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating hydrocortisone for Post-traumatic Stress Disorder has been withdrawn. The sponsor is University of California, San Diego.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Drugs mentioned

• HYDROCORTISONE (HYDROCORTISONE)

Snippet

Sponsor: University of California, San Diego | Conditions: Post-traumatic Stress Disorder | Phase 4 | Status: WITHDRAWN